Adverse events380

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 380

Type	Event	Organ system	Group	Affected	At risk	Events
other	COVID-19	Infections and infestations	Reldesemtiv Group, Double-Blind Period	30	325	30
other	COVID-19	Infections and infestations	Placebo Group, Double-Blind Period	13	161	13
other	COVID-19	Infections and infestations	Delayed Start Group, Active Drug Period	8	96	8
other	COVID-19	Infections and infestations	Early Start Group, Active Drug Period	12	180	12
other	urinary tract infection	Infections and infestations	Reldesemtiv Group, Double-Blind Period	20	325	20
other	urinary tract infection	Infections and infestations	Placebo Group, Double-Blind Period	9	161	9
other	urinary tract infection	Infections and infestations	Delayed Start Group, Active Drug Period	6	96	6
other	urinary tract infection	Infections and infestations	Early Start Group, Active Drug Period	13	180	13
other	nasopharyngitis	Infections and infestations	Reldesemtiv Group, Double-Blind Period	17	325	17
other	nasopharyngitis	Infections and infestations	Placebo Group, Double-Blind Period	6	161	6
other	nasopharyngitis	Infections and infestations	Delayed Start Group, Active Drug Period	3	96	3
other	nasopharyngitis	Infections and infestations	Early Start Group, Active Drug Period	2	180	2
other	fall	Injury, poisoning and procedural complications	Reldesemtiv Group, Double-Blind Period	58	325	58
other	fall	Injury, poisoning and procedural complications	Placebo Group, Double-Blind Period	23	161	23
other	fall	Injury, poisoning and procedural complications	Delayed Start Group, Active Drug Period	12	96	12
other	fall	Injury, poisoning and procedural complications	Early Start Group, Active Drug Period	27	180	27
other	constipation	Gastrointestinal disorders	Reldesemtiv Group, Double-Blind Period	26	325	26
other	constipation	Gastrointestinal disorders	Placebo Group, Double-Blind Period	12	161	12
other	constipation	Gastrointestinal disorders	Delayed Start Group, Active Drug Period	3	96	3
other	constipation	Gastrointestinal disorders	Early Start Group, Active Drug Period	10	180	10

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04944784/events

API reference For AI assistants

Adverse events380

Sources 3

Read this list from software.